AI
Saudi Arabia
UAE
EgyptBioSapien Boosts Pre-Series A to $8M with Globivest Backing
3 min
BioSapien has expanded its Pre-Series A funding round to over $8 million.
Globivest recently joined as a new investor, adding to previous backers like Global Ventures.
Their flagship product, MediChip, targets cancer treatment by delivering drugs directly to tumour sites.
This innovation aligns with the UAE's med-tech goals and supports regional startup growth.
BioSapien aims to transform this funding into a substantial, impactful healthcare solution.
When you’re knee-deep in the startup world, nothing says "we're on the right track" quite like investors coming back for more—or, indeed, new ones coming onboard. And believe it or not, that's exactly what's happened with UAE-based biotech startup, BioSapien. The innovative health-tech company has expanded its Pre-Series A funding round to north of $8 million, thanks to Globivest—the latest to jump into the fray.
This prized round didn't happen overnight, you know? BioSapien initially gathered $5.5 million back in December 2024, attracting heavy hitters like Global Ventures and Dara Holdings. Evidently, these investors didn’t think it was a bit of a faff putting in more cash: they upped their stake further in January 2025, pushing total funding up to a tidy $7 million. Now, with the latest batch from Globivest, funding has sailed comfortably past the eight-million-dollar mark—a pretty healthy sum by any stretch.
But what’s all the fuss about, I hear you say? At the heart of the excitement is BioSapien's flagship product, dubbed MediChip. It's a smartly-designed three-dimensional platform crafted specifically to fight cancer by delivering therapeutic drugs straight to tumour sites. This targeted approach significantly cuts down on nasty side effects—and frankly, that's spot on, considering chemotherapy's well-known and notorious harshness on patients' bodies.
I reckon this tech is a textbook example of what the UAE is aiming for when it comes to med-tech innovation—a perfectly aligned reflection of the country’s ambitions in health care. Particularly exciting for entrepreneurs here in our MENA startup ecosystem, as it genuinely embodies the sort of innovation Arageek loves championing to empower and ignite founders in our region.
Personally, I’m not a fan of overly complex healthcare solutions that are too tricky to scale, but BioSapien seems to have nailed simplicity by leveraging biodegradable, 3D-printed technology that's both practical and sustainable in the long run. Hats off to them! In all, looks like a promising addition to the regional startup ecosystem—and perhaps one to bookmark for future green-lit health innovations.
Still, financing is just part of the journey. Now BioSapien must turn those millions into a truly transformative solution, and that's the real test here. Watch this space, folks, things could get quite interesting.
🚀 Got exciting news to share?
If you're a startup founder, VC, or PR agency with big updates—funding rounds, product launches 📢, or company milestones 🎉 — AraGeek English wants to hear from you!
✉️ Send Us Your Story 👇